Effect of human immunodeficiency virus treatment on maternal mortality at a tertiary center in south africa: A 5-year audit

Obstetrics and Gynecology

Volumn 114, Issue 2, 2009, Pages 292-299

  Black, Vivian ^a   Brooke, Sebastian ^a   Chersich, Matthew F ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NEVIRAPINE;

ARTICLE; CAUSE OF DEATH; DEATH CERTIFICATE; FEMALE; HEALTH CARE FACILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LIVE BIRTH; MATERNAL MORTALITY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REGISTER; SEPSIS; SOUTH AFRICA; TERTIARY HEALTH CARE; TUBERCULOSIS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; CAUSE OF DEATH; FEMALE; HIV INFECTIONS; HUMANS; MATERNAL MORTALITY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOUTH AFRICA;

EID: 68949117568     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181af33e6     Document Type: Article

References (35)

1. Ronsmans CGW. Maternal mortality: who, when, where, and why. Lancet 2006;368:1189-200.
2. Hill K, Thomas K, AbouZahr C, Walker N, Say L, Inoue M, et al. Estimates of maternal mortality worldwide between 1990 and 2005: an assessment of available data. Lancet 2007;370:1311-9.
3. World Health Organization. Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA, and the World Bank. Available at: . Retrieved June 17, 2009.
4. Fawcus SR, van Coeverden de Groot HA, Isaacs S. A 50-year audit of maternal mortality in the Peninsula Maternal and Neonatal Service, Cape Town (1953-2002). BJOG 2005;112:1257-63.
5. National Department of Health South Africa. Maternal deaths 2003: National Committee for Confidential Enquiries into Maternal Deaths. Fourth Interim Report on Confidential Enquiries into Maternal Deaths in South Africa—Changing Patterns in Maternal Deaths 1998-2003. . Retrieved June 17, 2009.
6. National Department of Health South Africa. Saving mothers—report on confidential enquiries into maternal deaths in South Africa 2002-2004. Available at: . Retrieved June 17, 2009.
7. Ahmed Y, Mwaba P, Chintu C, Grange JM, Ustianowski A, Zumla A. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int J Tuberc Lung Dis 1999;3:675-80.
8. Bicego G, Boerma JT, Ronsmans C. The effect of AIDS on maternal mortality in Malawi and Zimbabwe. AIDS 2002;16:1078-81.
9. Khan M, Pillay T, Moodley JM, Connolly CA. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS 2001;15:1857-63.
10. Sewankambo NK, Gray RH, Ahmad S, Serwadda D, Wabwire-Mangen F, Nalugoda F, et al. Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS 2000;14:2391-400.
11. van Dillen J, Meguid T, van Roosmalen J. Maternal mortality audit in a hospital in Northern Namibia: the impact of HIV/AIDS. Acta Obstet Gynecol Scand 2006;85:499-500.
12. Department of Health South Africa. National HIV and syphilis antenatal seroprevalence survey in South Africa: 2007. Available at: . Retrieved June 17, 2009.
13. WHO, UNAIDS, UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2008. Available at: . Retrieved April 3, 2009.
14. Chigwedere P, Seage GR Gruskin S, Lee TH, Essex M. Estimating the Lost Benefits of Antiretroviral Drug Use in South Africa. J Acquir Immune Defic Syndr 2008 Oct 16 [Epub ahead of print].
15. Department of Health, Pretoria. South Africa Demographic and Health Survey 2003, Preliminary Report. Available at: . Retrieved June 17, 2009.
16. Black V, Hoffman RM, Sugar CA, Menon P, Venter F, Currier JS, et al. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2008;49:276-81.
17. Department of Health, South Africa. Policy and guidelines for the implementation of the PMTCT programme. Available at: . Retrieved April 3, 2009.
18. World Health Organization. Reproductive health indicators: guidelines for their generation, interpretation and analysis for global monitoring. Available at: . Retrieved September 15, 2007.
19. ICD-10. International statistical classification of diseases and related health problems: 10th revision. Geneva: World Health Organization; 1992.
20. World Health Organization. Beyond the numbers: Reviewing maternal deaths and complications to make pregnancy safer. Available at: . Retrieved June 17, 2009.
21. World Health Organization. WHO Antenatal care randomized trial: manual for the implementation of the new model. Available at: . Retrieved April 3, 2009.
22. Kirkwood B, Sterne J. Essentials of medical statistics. 2nd ed. Hoboken (NJ): Wiley-Blackwell; 2001.
23. Department of Health South Africa. National HIV and syphilis antenatal seroprevalence survey in South Africa: 2007. Available at: . Retrieved September 7, 2007.
24. Ramogale MR, Moodley J, Sebiloane MH. HIV-associated maternal mortality-primary causes of death at King Edward VIII Hospital, Durban. S Afr Med J 2007;97:363-6.
25. Bradshaw D, Chopra M, Kerber K, Lawn JE, Bamford L, Moodley J, et al. Every death counts: use of mortality audit data for decision making to save the lives of mothers, babies, and children in South Africa. Lancet 2008;371:1294-304.
26. Urban M, Chersich M. Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care. S Afr Med J 2004;94:362-6.
27. van der Merwe K, Chersich MF, Technau K, Umurungi Y, Conradie F, Coovadia A. Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa. J Acquir Immune Defic Syndr 2006;43:577-81.
28. Mapham W. Mobile phones: changing health care one SMS at a time. Southern African J HIV Med 2008;9:11-7.
29. USAID/Synergy. Women’s experiences with HIV serodisclosure in Africa: implications for VCT and PMTCT. Meeting Report. Washington (DC): 2004.
30. McIntyre JA. Sex, pregnancy, hormones, and HIV. Lancet 2005;366:1141-2.
31. Kebaabetswe PM. Barriers to participation in the prevention of mother-to-child HIV transmission program in Gaborone, Botswana a qualitative approach. AIDS Care 2007;19:355-60.
32. Nkonki LL, Doherty TM, Hill Z, Chopra M, Schaay N, Kendall C. Missed opportunities for participation in prevention of mother to child transmission programmes: simplicity of nevirapine does not necessarily lead to optimal uptake, a qualitative study. AIDS Res Ther 2007;4:27.
33. Chersich MF, Luchters SM, Yard E, Othigo JM, Kley N, Temmerman M. Morbidity in the first year postpartum among HIV-infected women in Kenya. Int J Gynaecol Obstet 2008;100:45-51.
34. Sebitloane HM, Mhlanga RE. Changing patterns of maternal mortality (HIV/AIDS related) in poor countries. Best Pract Res Clin Obstet Gynaecol 2008;22:489-99.
35. Graham W, Hussein J. Measuring and estimating maternal mortality in the era of HIV/AIDS. Workshop on HIV/AIDS and adult mortality in developing countries. Population Division, Department of Economic and Social Affairs, UN Secretariat. New York. Available at: . Retrived December 1, 2008.